# Amafin

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amafin

- Industry: Financial Services
- Headquarters: Berlin, Germany
- Website: www.myos.co
- Total disclosed funding: $30M
- Latest round: Series A (May 31, 2021)
- Investors on record: 10

## About

Amafin GmbH develops innovative health and wellness solutions with a focus on muscle health and recovery, providing dietary supplements and personalized nutrition plans to enhance physical performance.Founded in 2018 and headquartered in Berlin, Germany, Amafin GmbH specializes in health and wellness products targeted at muscle health. The company has completed 2 deals, with the most recent in May 2021, when it raised EUR 24.6 mn in a Series A round. The funding was co-led by new investors Fasanara Capital and Xploration Capital, with participation from various investors including Lifetime Ventures and Mountain Partners. The CEO and co-founder, Nikolaus Hilgenfeldt, has previously been involved in launching other ventures, contributing to the company's innovative approach.Amafin GmbH, through its brand Myos, offers a range of dietary supplements designed to enhance muscle growth, support recovery, and improve overall physical performance. Their products cater to athletes and fitness enthusiasts, offering personalized nutrition plans and coaching services. Distribution spans North America and Europe, targeting fitness centers, health professionals, and direct consumers.Amafin GmbH's revenue is primarily generated through direct-to-consumer sales and partnerships with health and fitness retailers. The company employs a subscription model for its dietary supplements, providing customers with regular shipments at competitive prices, alongside one-time purchases via retail and e-commerce platforms. Collaborations with fitness professionals enable bulk purchase agreements, widening market access and promoting customer loyalty.Following the EUR 24.6 mn raised in Series A funding in May 2021, Amafin GmbH plans to expand its customer base in Europe and enter international markets. The funds will support the development of new products focused on muscle health and enhancements to its AI-based lending platform. Specific geographic regions targeted for expansion will be outlined in future strategies.

## Funding rounds

- Series A, May 31, 2021, $30M — Mountain Partners, Berlin Technologie Holding, Avala Capital, Xploration Capital, about:seed GmbH, Lifetime Ventures, Tomahawk.vc, Evalue Family Office, Fasanara Capital, DD Venture Capital

## Investors

- Mountain Partners (https://capitalatlas.ai/funds/mountain-partners) — Series A
- Berlin Technologie Holding (https://capitalatlas.ai/funds/berlin-technologie-holding) — Series A
- Avala Capital (https://capitalatlas.ai/funds/avala-capital) — Series A
- Xploration Capital (https://capitalatlas.ai/funds/xploration-capital) — Series A
- about:seed GmbH — Series A
- Lifetime Ventures (https://capitalatlas.ai/funds/lifetime-ventures) — Series A
- Tomahawk.vc (https://capitalatlas.ai/funds/tomahawk-vc) — Series A
- Evalue Family Office — Series A
- Fasanara Capital — Series A
- DD Venture Capital (https://capitalatlas.ai/funds/dd-venture-capital) — Series A